Results 181 to 190 of about 27,184 (256)

Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World. [PDF]

Open Forum Infect Dis
de Gea-Grela A, Micán R, de Miguel R, Serrano L, Marcelo C, Montes ML, Ramos-Ruperto L, Busca C, Arcos-Rueda MDM, Montejano R, Arribas JR, Gonzalez-García J, Bernardino JI, Martín-Carbonero L.   +13 more
europepmc   +1 more source

Impact of bictegravir/emtricitabine/tenofovir alafenamide on health-related quality of life and economic outcomes in HIV care: Substudy of the BIC-NOW clinical trial. [PDF]

PLoS One
Sequera-Arquelladas S, Vivancos MJ, Vinuesa D, Collado A, Santos IL, Sorni P, Cabello-Clotet N, Montero M, Font CR, Terron A, Galindo MJ, Martinez O, Ryan P, Omar-Mohamed M, Albendín-Iglesias H, Javier R, Romero A, Vallecillos CG, Calleja MÁ, Hidalgo-Tenorio C.   +19 more
europepmc   +1 more source

Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 1, Page 132-144, January 2026.
Tenofovir alafenamide (TAF) has shown non‐inferior efficacy to tenofovir disoproxil fumarate (TDF), with superior bone and renal safety.
G. Wong, Edward Gane, Calvin Q. Pan, Scott Fung, Mang M Ma, Namiki Izumi, Shalimar, Seng Gee Lim, Wan-Long Chuang, R. Mehta, Young-Suk Lim, Leland J. Yee, John F Flaherty, F. Abramov, Hongyuan Wang, M. Buti   +15 more
semanticscholar   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Tenofovir-alafenamide

Reactions Weekly
semanticscholar   +4 more sources

Tenofovir Alafenamide

Annals of Pharmacotherapy, 2016
Objective: To review the pharmacology, efficacy, safety, and place in therapy for tenofovir alafenamide (TAF). Data Sources: A search using PubMed was conducted (2004 to May 2016) using the following keywords: tenofovir alafenamide, TAF, and GS-7340. Articles were evaluated for content, and bibliographies were reviewed.
Amanda K. Gibson, Bhavik M. Shah, Puja H. Nambiar, Jason J. Schafer   +3 more
openaire   +2 more sources

Bictegravir/emtricitabine/tenofovir alafenamide in clinical practice for people with HIV: final 24-month effectiveness and safety outcomes in key populations in the observational BICSTaR cohort

HIV Research & Clinical Practice
Background: BICtegravir Single Tablet Regimen (BICSTaR) is an observational cohort study evaluating the effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-naïve (TN) and treatment-experienced (TE) people ...
Benoit Trottier, Chia-Jui Yang, Dai Watanabe, G. Marchetti, D. Elbirt, E. de Barra, Alper Gündüz, Sun Hee Lee, R. Vogelmann, O. Robineau, C. Choy, Marvin Berrevoets, A. Uriel, D. Thorpe, Marion Heinzkill, A. Marongiu, Johanna Ramroth, Lisa D'Amato, Josep Mallolas   +18 more
semanticscholar   +1 more source